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Nuts for Diabetes Prevention and Management
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Antioxidants Research Lab., JM USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, U.S.A.

ABSTRACT
Type 2 diabetes mellitus is an important preventable disease and a growing public health problem. Epidemiologic and
clinical studies suggest that healthy eating, physical activity, and BW control are the main driving forces to reduce diabetes risk.
Owing to their low available carbohydrate content, favorable fat and protein profile as well as phytonutrient content, nut
consumption has been associated with a reduced risk of development and management of diabetes. Nuts, by virtue of its
cardioprotective actions, have also been shown to reduce biomarkers of risk factors for diabetic complications. Although more
studies are warranted, the emerging picture is that nut consumption beneficially influences diabetes risk and management beyond
blood glucose control.
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INTRODUCTION
The topic of this review is the health benefits of nuts
in diabetes prevention and management. We first provide
background information about diabetes. We next discuss
nuts as components of a healthy diet for glycemic control
in people with diabetes or at risk for developing diabetes.
Finally, as nuts contain a variety of nutrients exerting cardioprotective, antioxidant, and anti-inflammatory actions,
we will present studies demonstrating how nuts could
ameliorate biomarkers of risk factors for diabetic complications.

DIABETES INCIDENCE AND MANAGEMENT
Diabetes is characterized by hyperglycemia and glucose intolerance due to insulin deficiency and/or impaired
effectiveness of action. As of 2007, roughly 6% were affected worldwide and it is estimated that this will increase
to 7.3% by 2025(1). Fueled by rapid urbanization, nutrition
transition, and increasingly sedentary lifestyles, Asia accounts for 60% of the world’s diabetic population(2). Type
2 diabetes mellitus (T2DM) is by far the most common
disorder, affecting 90 - 95% of the U.S. diabetes population(3).
Several factors contribute to the development of
T2DM, including family history, ethnicity, age, genetics,
lifestyle, diet, and body weight (BW). Excess BW, particularly abdominal adiposity is the most important modifiable risk factor for development of diabetes. The incidence of diabetes clearly rises as obesity prevalence increases(4,5). Furthermore, diet quality especially of fats and
carbohydrates (CHO) play an important role, independent

of BMI and other risk factors(5). There is also strong evidence for an inverse association between physical activity
and the risk of diabetes(6).
Healthy eating, physical activity, and BW control are
the cornerstones of diabetes prevention or management.
The major medical nutrition therapy recommendations
provided by the American Diabetes Association (ADA)
include moderate weight loss and regular physical activity,
with dietary strategies including reduced calories and intake of dietary fat. Recommended foods include: healthy
CHO such as whole grains, fruits, vegetables, legumes,
and low-fat dairy; heart healthy fish; good fats high in
monounsaturated (MUFA) and polyunsaturated fatty acids
(PUFA). Foods to limit include: bad fats high in saturated
(SFA) or trans-fatty acids; sodium; and alcohol(7). Hence,
the application of nutritional therapy to lower the risk or
delay the onset of diabetes is important.

NUTRITION COMPOSITION
“Tree-nuts” or nuts are a nutrient dense food that
contains diverse macro and micronutrients and other phytochemicals that may have beneficial effects on T2DM and
other health complications(8). Nuts are rich in magnesium,
which helps regulate blood sugar levels and is involved in
energy metabolism. Nuts are also a good source of dietary
fiber which decreases gastric emptying, in turn decreasing
the rates of CHO breakdown and glucose absorption. Furthermore, nuts are high in unsaturated fats, mostly high in
MUFA in most nuts and PUFA in walnuts. Their unsaturated fats appear to exert anti-inflammatory and lipid lowering effects. L-arginine is also an important constituent of
nuts that is essential to vascular function. Nuts contain an
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array of phytonutrients, e.g., carotenoids, phenolics, and
phytosterols, which exert antioxidant and anti-inflammatory actions as well as an inhibitory effect on
starch digestive enzymes. Incorporation of nuts into a diet
may therefore improve the overall nutritional quality of the
diet.

NUTS AND DIABETES PREVENTION
Jiang et al.(9) observed in the Nurses’ Health Study
that women consuming a 1 oz serving of nuts >5 times/wk
had a 25% lower risk of developing T2DM compared with
women who never ate nuts. Recently, the PREDIMED
study(10) with 418 persons at high cardiovascular risk
showed that a traditional high-fat Mediterranean diet enriched with mixed nuts (30 g/d) or olive oil decreased the
incidence of diabetes by 50% after a median follow-up of
4 yrs compared to a control diet consisting of advice on a
low-fat diet.
Owing to their low available CHO content and favorable fat profile, nuts may decrease the risk of diabetes
by reducing postprandial blood glucose levels. This is important as chronic hyperglycemia causes damage to the
eyes, kidneys, nerves, and blood vessels. Kendall et al.(11)
examined the effect of pistachios on postprandial glycemic
response, in a two stage study with 10 healthy overweight
subjects. Addition of pistachios to 50 g available CHO
resulted in a significant reduction in the glycemic response
of the composite meal in a dose-dependent manner for the
28 g (5.7%), 56 g (3.8%), and 84 g (9.3%). Likewise, addition of 56 g pistachios to CHO foods significantly attenuated their glycemic response: parboiled rice (19%) and
pasta (40%). Similarly, Josse et al.(12) found that the addition of almonds to white bread with 50 g CHO resulted in
a progressive reduction in the glycemic index of the composite meal in a dose-dependent manner for the 30 g
(105.8), 60 g (63.0), and 90 g (45.2) in 9 healthy volunteers. Furthermore, since the nutrient bio-accessibility of
nuts consumed in different physical forms might be different, Mori et al.(13) reported in a randomized crossover
trial with 14 patients with impaired glucose tolerance (IGT)
that 42.5 g whole almonds, but not comparable amounts of
almond butter or defatted almond flour, added to a 75 g
available CHO-matched meal decreased postprandial glucose response compared to a no almond vehicle.
Given the rapidly increasing obesity prevalence, nuts
may decrease the risk of diabetes through weight management. Bes-Rastrollo et al.(14) reported in the Nurses’
Health Study II with an 8 yr follow-up that women eating
nuts >2 times/wk had slightly less mean weight gain (5.04
kg) than did women who rarely ate nuts (5.55 kg). Moreover, Wien et al.(15) assessed the effect of an almond-enriched (84 g/d) or complex-CHO-enriched low
calorie diet (1012 kcal/d) on anthropometric, body composition and metabolic parameters in a randomized prospective 24 wk trial with 65 overweight and obese subjects. As
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low fat diets (≤ 20% kcal) have been shown to have poor
adherence in the outpatient treatment of obesity(16), alternative approaches with more moderate fat content (35%
kcal, < 10% from SFA) which increases palatability may
enhance compliance to weight loss diets. Wien et al. reported reductions in BW, BMI, waist circumference, and
fat mass being 62, 62, 50, and 56% greater, respectively,
than the control diet. The above lack of effect of nut consumption on weight gain could be attributed to the observed calorie displacement from other foods, satiating and
palatability properties of nuts, and the probable modest
malabsorption of nut fats(17). Thus, nuts could be a part of a
balanced, healthy diet for glycemic and BW management.

NUTS AND DIABETES MANAGEMENT
According to the ADA, the primary objective in
management of diabetes is achievement of targeted glycemic control (HbA1C < 7%)(18). Besides the acute trials
above showing reductions in postprandial glycemia in individuals at risk for development of T2DM, up to date
there are 4 clinical trials demonstrating the effect of nuts
on glycemic control in T2DM patients. Cohen & Johnston
(19)
reported in a 12 wk randomized crossover trial with
T2DM patients that consumption of 28.4 g/d almonds at a
frequency of 5 d/wk decreased HbA1c as compared to a
control diet without almonds (4% reduction vs. 1% increase, respectively). Li et al.(20) demonstrated in a randomized, crossover, controlled trial that almonds (60 g/d)
replacing 20% calories of the control National Cholesterol
Education Program (NCEP) Step 2 diet significantly decreased fasting blood glucose and insulin and HOMA insulin resistance as compared to the control diet. After a 42
wk intervention with an almond-based, high fat and protein diet (40, 22, and 25% kcal from fat, MUFA, and protein, respectively) vs. a contemporary American Heart Association diet (30, 15, and 15% kcal, respectively) in 17
patients with metabolic syndrome or T2DM, Scott et al.(21)
noted that the former diet was modestly better in glycemic
control. Jenkins et al.(22) reported in a 3 mo randomized
parallel study with 117 T2DM subjects that supplementation with mixed nuts (75 g/d) to a 2,000 kcal diet in replacement for CHO foods significantly reduced HbA1c
21% compared to supplementation with half-nut dose or
muffin. Hence, frequent nut consumption has a beneficial
effect for blood glucose control in T2DM patients as part
of a strategy to improve diabetes control.

BENEFITS BEYOND GLUCOSE CONTROL
Diabetes is associated with a myriad of other health
complications that include cardiovascular disease (CVD),
hypertension, cancers, and renal and gallstone disease.
More specifically, of these patients with diabetes or IGT,
75% will die of some form of CVD(23). Thus, the expanded
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goals of diabetes management, besides slowing or stopping
disease progression, must include optimizing the reduction
of all risk factors associated with disease complications. A
pooled analysis of epidemiologic studies shows a clear
dose response between nut consumption and a reduced risk
of coronary heart disease (CHD)(24). Collectively, these
findings provide compelling evidence of the cardioprotective benefit of nut consumption.
Dietary intervention studies have shown that nut consumption can reduce the risk of heart disease by improving
serum lipid profile, endothelial function and blood pressure, in addition to lowering oxidative stress and inflammation. A pooled analysis of 25 intervention studies(25)
evaluating the effect of nuts on blood lipids among people
with normolipidemia and hypercholesterolemia, demonstrated significant reductions in both total cholesterol
(5.1%) and LDL-C (7.4%) with a mean daily consumption
of 67 g of nuts and greatest among subjects with high
LDL-C or with lower BMI consuming Western diets.
Moreover, walnuts are the only nuts that have been formally studied for effects on endothelial function, which is
important as endothelial dysfunction has been shown to be
predictive of future adverse cardiovascular events. In a
randomized, controlled crossover trial with 24 participants
with T2DM(26), endothelial function as measured by
flow-mediated dilation (FMD) was significantly improved
after consumption of a walnut enriched diet (56 g/d) compared to a control diet without walnuts (2.2 vs. 1.2%, respectively). Similarly, Ros et al.(27) demonstrated in a randomized crossover design with 21 hypercholesterolemic
subjects that replacement of ~32% of the energy with
walnuts significantly improved FMD compared to a control diet without walnuts with a similar energy and fat
content. Further studies are needed to confirm that overall
nut intake influences endothelial function. To note, few
studies have examined the effect of nut consumption on
incidence of hypertension. However, the result of the Physicians’ Health Study I showed there was an inverse relation between nut intake and hypertension among U.S. male
physicians (BMI < 25)(28). Further examination of the relation between nuts and incident of hypertension in the general population and differential effects of types of nuts
consumed is warranted, as well as mechanism of action.
Evidence also suggests a protective role of nuts
against biomarkers of CVD such as susceptibility to oxidation and inflammation. Oxidation markers after feeding
nuts have been examined in several clinical trials. Jenkins
et al.(29) compared diets supplemented for 4 wks with 2
almond doses (36.5 or 73 g/d) with a similar diet supplemented with muffins in 27 hypercholesterolemic subjects.
The almond diets significantly increased the resistance of
LDL-C to oxidation and decreased serum MDA and urinary isoprostanes. Furthermore, in a randomized crossover
clinical trial with 60 healthy young male soldiers who
were habitual smokers, Li et al.(30) reported that supplementation with 84 g almonds daily for 4 wks resulted in a
significant decrease in lymphocyte DNA strand breaks as
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compared to isocaloric pork (120 g/d). They also demonstrated that adding almonds led to increased activities of
serum superoxide dismutase and glutathione peroxidase,
but not changed after pork. Inflammation also plays a critical role in the risk for and progression of CVD and T2DM
such that biomarkers like C-reactive protein (CRP) and
interleukin-6 (IL-6) are independent predictors of their
pathology. An anti-inflammatory action by nuts is consistent with the observation that frequency of nut and seed
consumption is inversely associated with each of these
biomarkers(31). In a randomized, controlled, crossover
clinical trial with healthy adults, Rajaram et al.(32) found
incorporating almonds into the diet at 10 and 20% of calories (34 and 68 g/2000 kcal, respectively) for 4 wks lowered CRP compared to a nut-free control diet, although no
dose-response relationship was observed. E-selectin, a cell
adhesion molecule activated by cytokines during inflammation, was also significantly lower, but only with the
higher almond dose. These results suggest that nuts can
enhance antioxidant defenses and diminish inflammation
and oxidative stress. More studies are warranted to elucidate the mechanism of actions for these reductions in biomarkers.

CONCLUSION
The available data demonstrate that nuts as replacement for CHO have beneficial effects on diabetes risk and
management. In general, the nutrient composition of nuts
and emerging clinical evidence provide a strong justification in support that they could be a part of a balanced,
healthy diet for glycemic, BW management, and cardioprotection. More research with robust study designs are
needed to better identify differential effects of different
types of nuts as well as the benefits in the longer term.

REFERENCES
1.
2.
3.

4.

5.

International Diabetes Federation. 2011. Diabetes
AtlasPrevalence
and
Projections.
http://da3.diabetesatlas.org/index2983.html.
Hu, F. B. 2011. Globalization of Diabetes: The role
of diet, lifestyle, and genes. Diabetes Care. 34:
1249-1257.
World Health Organization. 1994. Prevention of
diabetes mellitus. Technical Report Series no. 844.
Geneva: World Health Organization. Geneva,
Switzerland.
Mokdad, A. H., Bowman, B. A., Ford, E. S.,
Vinicor, F., Marks, J. S. and Koplan, J. P. 2001.
The continuing epidemics of obesity and diabetes
in the United States. JAMA. 286: 1195-1200.
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz,
G., Liu, S., Solomon, C. G. and Willett, W. C.

2012/4/24 下午 03:28:46

326

6.

7.

8.
9.

10.

11.

12.

13.

14.

15.

16.

ICoFF論文集.indd 326

Journal of Food and Drug Analysis, Vol. 20, Suppl. 1, 2012

2001. Diet, lifestyle, and the risk of type 2 diabetes
mellitus in women. N. Engl. J. Med. 345: 790-797.
Hu, F. B., Li, T. Y., Colditz, G. A., Willett, W. C.
and Manson, J. E. 2003. Television watching and
other sedentary behaviors in relation to risk of
obesity and type 2 diabetes mellitus in women.
JAMA. 289: 1785-1791.
Mann, J. I. 2006. Nutrition recommendations for
the treatment and prevention of type 2 diabetes and
the metabolic syndrome: an evidenced-based
review. Nutr. Rev. 64: 422-427.
USDA
National
Nutrient
Database.
http://www.nal.usda.gov/fnic/foodcomp/search.
Jiang, R., Manson, J. E., Stampfer, M. J., Liu, S.,
Willett, W. C. and Hu, F. B. 2002. Nut and peanut
butter consumption and risk of type 2 diabetes in
women. JAMA. 288: 2554-2560.
Salas-Salvadó, J., Bulló, M., Babio, N.,
Martínez-González, M. Á., Ibarrola-Jurado, N.,
Basora, J., Estruch, R., Covas, M. I., Corella, D.,
Arós, F., Ruiz-Gutiérrez, V., Ros, E. and Predimed
study investigators. 2010. Reduction in the
incidence of type 2- diabetes with the
Mediterranean
diet:
results
of
the
PREDIMED-Reus
nutrition
intervention
randomized trial. Diabetes Care. 34: 14-19.
Kendall, C. W., Josse, A. R., Esfahani, A. and
Jenkins, D. J. 2011. The impact of pistachio intake
alone or in combination with high-carbohydrate
foods on post-prandial glycemia. Eur. J. Clin. Nutr.
65: 696-702.
Josse, A. R., Kendall, C. W., Augustin, L. S., Ellis,
P. R. and Jenkins, D. J. 2007. Almonds and
postprandial glycemia--a dose-response study.
Metabolism. 56: 400-404.
Mori, A. M., Considine, R. V., Mattes, R. D. 2011.
Acute and second-meal effects of almond form in
impaired glucose tolerant adults: a randomized
crossover trial. Nutr. Metab. 8(1): 1-8.
Bes-Rastrollo,
M.,
Wedick,
N.
M.,
Martinez-Gonzalez, M. A., Li, T. Y., Sampson, L.
and Hu, F. B. 2009. Prospective study of nut
consumption, long-term weight change, and obesity
risk in women. Am. J. Clin. Nutr. 89: 1913-1919.
Wien, M. A., Sabaté, J. M., Iklé, D. N., Cole, S. E.
and Kandeel, F. R. 2003. Almonds vs complex
carbohydrates in a weight reduction program. Int. J.
Obes. Relat. Metab. Disord. 27: 1365-1372.
Howards, B. V., Van Horn, L., Hsia, J., Manson, J.
E., Stefanick, M. L., Wassertheil-Smoller, S.,
Kuller, L. H., LaCroix, A. Z., Langer, R. D.,
Lasser, N. L., Lewis, C. E., Limacher, M. C.,
Margolis, K. L., Mysiw, W. J., Ockene, J. K.,
Parker, L. M., Perri, M. G., Phillips, L., Prentice,
R. L., Robbins, J., Rossouw, J. E., Sarto, G. E.,
Schatz, I. J., Snetselaar, L. G., Stevens, V. J.,
Tinker, L. F., Trevisan, M., Vitolins, M. Z.,

17.

18.
19.

20.

21.

22.

23.
24.

25.

26.

27.

Anderson, G. L., Assaf, A. R., Bassford, T.,
Beresford, S. A., Black, H. R., Brunner, R. L.,
Brzyski, R. G., Caan, B., Chlebowski, R. T., Gass,
M., Granek, I., Greenland, P., Hays, J., Heber, D.,
Heiss, G., Hendrix, S. L., Hubbell, F. A., Johnson,
K. C. and Kotchen, J. M. 2006. Low-fat dietary
pattern and risk of cardiovascular disease. JAMA.
295: 655-666.
Ellis, P. R., Kendall, C. W., Ren, Y., Parker, C.,
Pacy, J. F., Waldron, K. W. and Jenkins, D. J. 2004
Role of cell walls in the bioaccessibility of lipids in
almond seeds. Am. J. Clin. Nutr. 80: 604-613.
American Medical Association. 2001. Standards of
medical care in diabetes. Diabetes Care. 34:
S11-S61.
Cohen, A. E. and Johnston, C. S. 2011. Almond
ingestion at mealtime reduces postprandial
glycemia and chronic ingestion reduces
hemoglobin
A1c
in
individuals
with
well-controlled type 2 diabetes mellitus.
Metabolism 60: 1312-1317.
Li, S. C., Liu, Y. H., Liu, J. F., Chang, W. H.,
Chen, C. M. and Chen, C. Y. 2010. Almond
consumption improved glycemic control and lipid
profiles in patients with type 2 diabetes mellitus.
Metabolsim. 60: 474-479.
Scott, L. W., Balasubramanyam, A., Kimball, K.
T., Aherns, A. K., Fordis, C. M. Jr. and Ballantyne,
C. M. 2003. Long-term, randomized clinical trial of
two diets in the metabolic syndrome and type 2
diabetes. Diabetes Care. 26: 2481-2482.
Jenkins, D. J., Kendall, C. W., Banach, M. S.,
Srichaikul, K., Vidgen, E., Mitchell, S., Parker, T.,
Nishi, S., Bashyam, B., de Souza, R., Ireland, C.
and Josse, R. G. 2011. Nuts as a replacement for
carbohydrates in the diabetic diet. Diabetes Care.
34: 1706-1711.
Heinig, R. E. 2006. The patient with diabetes:
Preventing cardiovascular complications. Clin.
Cardiol. 29: 13-20.
Kris-Etherton, P. M., Hu, F. B., Ros, E., Sabaté, J.
2008 The role of tree nuts and peanuts in the
prevention of coronary heart disease: multiple
potential mechanisms. J. Nutr. 138: 1746S-1751S.
Sabate,´ J., Oda, K. and Ros, E. 2010. Nut
consumption and blood lipid levels: a pooled
analysis of 25 intervention trials. Arch. Intern.
Med. 170: 821-827.
Ma, Y., Njike, V. Y., Millet, J., Dutta, S., Doughty,
K., Treu, J. A. and Katz, D. L. 2010. Effects of
walnut consumption on endothelial function in type
2 diabetic subjects: a randomized controlled
crossover trial. Diabetes Care. 33: 227-232.
Ros, E., Núñez, I., Pérez-Heras, A., Serra, M.,
Gilabert, R., Casals, E. and Deulofeu, R. 2004. A
walnut diet improves endothelial function in
hypercholesterolemic subjects: a randomized

2012/4/24 下午 03:28:47

327

Journal of Food and Drug Analysis, Vol. 20, Suppl. 1, 2012

28.
29.

30.

ICoFF論文集.indd 327

crossover trial. Circulation 109: 1609-1614.
Djousse´, L., Rudich, T. and Gaziano, J. M. 2009.
Nut consumption and risk of hypertension in US
male physicians. Clin. Nutr. 28: 10-14.
Jenkins, D. J. A., Kendall, C. W., Josse, A. R.,
Salvatore, S., Brighenti, F., Augustin, L. S., Ellis,
P. R., Vidgen, E. and Rao, A. V. 2006. Almonds
decrease postprandial glycemia, insulinemia, and
oxidative damage in healthy individuals. J. Nutr.
136: 2987-2992.
Li, N., Jia, X., Chen C. Y., Blumberg, J. B., Song,
Y., Zhang, W., Zhang, X., Ma, G. and Chen, J.
2007. Almond consumption reduces oxidative
DNA damage and lipid peroxidation in male

31.

32.

smokers. J. Nutr. 137: 2717-2722.
Jiang, R., Jacobs, D. R. Jr., Mayer-Davis, E., Szklo,
M., Herrington, D., Jenny, N. S., Kronmal, R. and
Barr, R. G. 2006. Nut and seed consumption and
inflammatory markers in the multi-ethnic study of
atherosclerosis. Am. J. Epidemiol. 163: 222-231.
Rajaram, S., Connell K. M. and Sabaté, J. 2010.
Effect of almond-enriched high-monounsaturated
fat diet on selected markers of inflammation: a
randomised, controlled, crossover study. Br. J.
Nutr. 103: 907-912.

2012/4/24 下午 03:28:47

